| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/22/2001 | WO2001012793A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012236A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 02/22/2001 | WO2001012235A2 Targeted artificial gene delivery |
| 02/22/2001 | WO2001012234A1 Gene transfer imaging and uses thereof |
| 02/22/2001 | WO2001012231A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 02/22/2001 | WO2001012215A2 Protective antigen of epstein barr virus |
| 02/22/2001 | WO2001012213A2 Ttp-related zinc finger domains and methods of use |
| 02/22/2001 | WO2001012210A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | WO2001012154A2 Targeted lipid particles |
| 02/22/2001 | WO2001012126A2 Cardiomyocyte regeneration |
| 02/22/2001 | WO2001011960A1 A mucosal specific gene delivery system based on modified bacterial exotoxin |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000073329A3 Uses of notch related genes |
| 02/22/2001 | WO2000072863A3 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 02/22/2001 | WO2000072742A3 Methods and materials for generating sh3 domains with tailored binding properties |
| 02/22/2001 | WO2000071737A3 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/22/2001 | WO2000063385A3 Nucleic acid immunization |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO2000023100A8 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19939095A1 Von Coxsackieviren abgeleitetes Vektorsystem für Gentransfer Of coxsackie-derived vector system for gene transfer |
| 02/22/2001 | DE19937837A1 New human gene OLFXX, encoding an olfactory receptor, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/22/2001 | DE19910108C2 Zellen, die ein Amyloidvorläuferprotein und eine alpha-Sekretase coexprimieren, ein Testverfahren zur Identifikation alpha-Sekretase-aktiver Substanzen sowie eines zur Identifikation weiterer Sekretasen, ein Testverfahren zur Bestimmung der Anfälligkeit gegenüber Morbus Alzheimer und Verwendung von Nukleinsäuren, die für eine alpha-Sekretase codieren, für die Gentherapie Cells, which co-express an amyloid precursor protein and an alpha-secretase, a test method for identifying alpha-secretase active substances as well as one further for identifying secretases, a test method for determining the susceptibility to Alzheimer's disease, and use of nucleic acids encoding an alpha-secretase , for gene therapy |
| 02/22/2001 | CA2784789A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2382090A1 Coxsackie virus-derived vector system for gene transfer |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2381993A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381712A1 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | CA2380991A1 Protective antigen of epstein barr virus |
| 02/22/2001 | CA2380966A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | CA2380953A1 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 02/22/2001 | CA2380517A1 Targeted artificial gene delivery |
| 02/22/2001 | CA2379431A1 Targeted lipid particles |
| 02/22/2001 | CA2378708A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 02/22/2001 | CA2346127A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 02/21/2001 | EP1076723A2 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 02/21/2001 | EP1076715A1 Novel lentiviral packaging cells |
| 02/21/2001 | EP1076713A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 02/21/2001 | EP1076694A1 Methods and substances for preventing and treating autoimmune disease |
| 02/21/2001 | EP1076569A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 02/21/2001 | EP1076566A1 ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
| 02/21/2001 | EP0835238B1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0652968B1 Defective adenoviruses |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1285000A Equine infections anaemia virus (EIAV) based |
| 02/21/2001 | CN1284996A Tumor antigen protein, gene thereof, and utilization thereof |
| 02/21/2001 | CN1284883A Method to enhance an immune response of nucleic acid vaccination |
| 02/21/2001 | CN1284383A Ejecting pneumatic gene accelerating microejection method and gene gun |
| 02/20/2001 | US6191269 Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
| 02/20/2001 | US6191266 Sugar modified nucleosides |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191257 Natural or recombinant DNA binding proteins as carriers for gene transfer or gene therapy |
| 02/20/2001 | US6191254 Of given amino acid sequences |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6190912 Nucleotide sequences coding modulator of cell killing; for the treatment of cell proliferation defects |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190907 Nucleotide sequences for the transfer of heterologous genes; for treatment of human defects |
| 02/20/2001 | US6190887 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190866 Selecting bacterial target gene, preparing peptide nucleic acid having region complementary to target, identifying active peptide nucleic acid, contacting bacteria with active compounds, and determining effect on bacteria; bactericides |
| 02/20/2001 | US6190669 Attenuated mutants of salmonella which constitutively express the Vi antigen |
| 02/20/2001 | US6190659 For thrombolytic therapy in treatment of coronary and pulmonary thrombosis; in vaccines to abrogate streptococcal infection |
| 02/20/2001 | US6190657 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 02/20/2001 | US6190655 Methods of using Flt-3 ligand for exogenous gene transfer |
| 02/20/2001 | CA2199403C Novel pka-binding proteins and uses thereof |
| 02/15/2001 | WO2001011369A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | WO2001011086A2 Methods of screening for angiogenesis modulators |
| 02/15/2001 | WO2001011068A2 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011066A1 Non-human adenoviral vector for gene transfer, its use and the production thereof |
| 02/15/2001 | WO2001011064A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011048A2 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |